Fondaparinux or enoxaparin: A comparative study of postoperative bleeding in coronary artery bypass grafting surgery
暂无分享,去创建一个
[1] Neykova Anna,et al. The HIT treatment in a cardiac surgery patient. , 2010, International journal of cardiology.
[2] I. Ennker,et al. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting. , 2009, The Thoracic and cardiovascular surgeon.
[3] Yang Xiao-ming. The effect of inhalation anesthetics on myocardial protection in coronary artery bypass grafting-a meta analysis , 2009 .
[4] S. Steinhubl,et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. , 2008, Journal of the American College of Cardiology.
[5] S. Bates,et al. Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis , 2008, American journal of hematology.
[6] D. Mark,et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. , 2008, American heart journal.
[7] C. Hamm,et al. Guidelines for anticoagulant use in acute coronary syndromes , 2008, The Lancet.
[8] G. Guyatt,et al. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[9] G. Guyatt,et al. Guidelines for anticoagulant use in acute coronary syndromes , 2008, The Lancet.
[10] A. Turpie. Selective factor Xa inhibition with fondaparinux: from concept to clinical benefit , 2008 .
[11] J. Bassand. The place of fondaparinux in the ESC and ACC/AHA guidelines for anticoagulation in patients with non-ST elevation acute coronary syndromes , 2008 .
[12] William Wijns,et al. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[13] S. Yusuf,et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. , 2007, Journal of the American College of Cardiology.
[14] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.
[15] Y. Choi,et al. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. , 2007, The Journal of thoracic and cardiovascular surgery.
[16] J. Bassand,et al. Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm. , 2007, European heart journal.
[17] D. Torchiana,et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. , 2007, The Annals of thoracic surgery.
[18] J. Dunning,et al. Should clopidogrel be stopped prior to urgent cardiac surgery? , 2006, Interactive cardiovascular and thoracic surgery.
[19] Fondaparinux versus enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.
[20] Salim Yusuf,et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.
[21] S. Yusuf,et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.
[22] A. Darzi,et al. Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis , 2005, Heart.
[23] M. Kuduvalli,et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] J. Kelton,et al. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. , 2005, Blood.
[25] W. Byerly,et al. Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting. , 2003, The Annals of thoracic surgery.
[26] A. Siegbahn,et al. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. , 1999, Lancet.
[27] J S Alpert,et al. Acute coronary syndromes. , 1997, Cardiology.